GeNeuro SA
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical tr…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
GeNeuro SA has no obligation with a government/award agency.
Latest Obligations
- No trends presentable at the moment.
Spending By Type
GeNeuro SA can't present spending by time.
Contract Analysis
Palmy tracks high-doted primary awards as well as their sub contracts on a regular basis.
This empowers you to dive deeper to unveil recent changes, risks and products/services GeNeuro SA
offers.
There are no contract award details available for GeNeuro SA